| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $4.9M | +7.5% |
| Cost of Revenue | $3.2M | -7.5% |
| Gross Profit | $1.7M | +55.0% |
| R&D Expense | $2.9M | -24.2% |
| SG&A Expense | $6.6M | +24.9% |
| Pre-tax Income | -$8.2M | -6.4% |
| Income Tax | $7K | +0.0% |
| Net Income | -$8.2M | -6.3% |
| EPS (Basic) | -$8.36 |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.1M | +68.5% |
| Short-term Investments | $43K | +0.7% |
| Accounts Receivable | $465K | +31.8% |
| Inventory | $961K | -22.8% |
| Current Assets | $12.9M | +48.1% |
| Total Assets | $15.6M | +31.8% |
| Current Liabilities | $1.8M | -6.7% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.8M | -11.2% |
| Capital Expenditures | $9K | +0.0% |
| Investing Cash Flow | -$9K | +0.0% |
| Financing Cash Flow | $12.3M | +163.7% |
| Free Cash Flow | -$7.8M | -11.2% |
| -727.7% |
| EPS (Diluted) | -$8.36 | -727.7% |
| Total Liabilities |
| $2.1M |
| -18.0% |
| Stockholders' Equity | $13.4M | +45.9% |